New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 27, 2011
14:07 EDTMRKEarnings Preview: Merck trading up ahead of Q3 earnings
Merck (MRK) is expected to report Q3 earnings before the market open on Friday, October 28 with a conference call scheduled for 8:00 am ET. Analysts are looking for EPS of 91c on revenue of $11.61B. The consensus range is 83c-93c for EPS, and $11.47B-$11.95B for revenue, according to First Call. In Q2, Merck reported in-line EPS and better-than-expected revenue. It also reported sales growth for Singular, Remicade, and Animal Health, while raising the full-year EPS to $3.68-$3.76. In its previous conference call, the company announced plans to reduce the workforce by 12%-13% by 2015. The measure would save the company $3.5B by the end of FY12. To accelerate the goal, the Associated Press reported the company may speed up the layoffs to reach that goal. In the previous quarter, Merck announced positive clinical results for several drugs: Isentress, Delura, Odanacatib, and Gardasil. In fact, the CDC voted to expand the use of Gardasil. Investors will also look for updates on the progress of its new type 2 diabetes treatment Juvisync, which recently received FDA approval. Meanwhile, the company signed various research and colloboration agreements with AbD Serotec, Serum Institute of India, and BGI. The company may also mention its sale of its 50% interest in the Johnson & Johnson-Merck joint venture for $175M. Merck was upgraded to Buy at Jeffries, citing valuation and capital allocation. Barron's also said Merck was attractive for its dividend yield, restructuring savings, and expansion in emerging markets.
News For MRK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 24, 2014
13:35 EDTMRKMerck weekly volatility elevated into Q3 and outlook
Subscribe for More Information
October 22, 2014
07:35 EDTMRKCardiometabolic Health Congress to hold annual meeting
Subscribe for More Information
October 20, 2014
08:06 EDTMRKMerck, Sanofi unit announce pediatric hexavalent vaccine BLA
Subscribe for More Information
07:34 EDTMRKAdvaxis names Mauro Chief Medical Officer
Advaxis (ADXS) announced that it has appointed David Mauro, as executive vice president, Chief Medical Officer Mauro most recently served as executive director, section head oncology clinical development at Merck (MRK). In connection with his appointment, Mauro received a one-time inducement award of 165K restricted shares, of which 55K are fully vested and as of the grant date. The remaining shares vest annually over a two-year period.
07:19 EDTMRKIBC Life Sciences to hold a conference
Subscribe for More Information
07:11 EDTMRKAmerican Society for Reproductive Medicine to hold annual meeting
2014 Annual Meeting of ASRM is being held in Honolulu on October 18-22.
October 17, 2014
07:58 EDTMRKDeutsche Bank specialty pharma analyst holds analyst/industry conference call
Specialty Pharmaceuticals Analyst Gilbert provides of preview of The Improved Reduction of Outcomes: Vytorin Efficacy Internal Study (IMPROVE-IT) on an Analyst/Industry conference call to be held on October 17 at 10 am.
October 15, 2014
12:42 EDTMRKNY AG announces $31M Medicaid settlement with Organon
Subscribe for More Information
09:57 EDTMRKLeerink biotech analysts hold an analyst/industry conference call
Subscribe for More Information
October 14, 2014
11:23 EDTMRKBIND Therapeutics and The Conference Forum hold a conference
Subscribe for More Information
October 13, 2014
07:37 EDTMRKAmerican Society of Anesthesiologists to hold annual meeting
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use